Company Overview - BioSyent Inc. is a profitable growth-oriented specialty pharmaceutical company listed on the TSX Venture Exchange under the symbol "RX" [3] - The company focuses on in-licensing or acquiring innovative pharmaceutical and healthcare products that are safe, effective, and have a proven track record of improving patient lives [3] Upcoming Conference Participation - BioSyent will attend the Planet MicroCap Showcase: VEGAS 2025 investor conference in Las Vegas from April 22 to April 24, 2025 [1] - Mr. René Goehrum, President and CEO, will present at the conference on April 23 from 12:30pm to 1:00pm PDT in Track 2 – Bordeaux [1] - One-on-one meetings with investors will be available on April 23 from 1:30pm to 6:00pm PDT and on April 24 from 8:00am to 5:00pm PDT [2] Share Information - As of the date of the press release, BioSyent has 11,254,638 common shares outstanding [4]
BioSyent to Attend Planet MicroCap Showcase
Globenewswire·2025-04-14 21:30